CPIG
TXG icon

Chicago Partners Investment Group’s 10x Genomics TXG Stock Holding History

Chicago Partners Investment Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.9M Sell
39,561
-10,383
-21% -$272K 0.04% 388
2026
Q1 		$1.14M Buy
49,944
+7,153
+17% +$143K 0.03% 491
2025
Q4 		$958K Buy
42,791
+5,540
+15% +$83.7K 0.02% 489
2025
Q3 		$497K Buy
37,251
+13,227
+55% +$172K 0.01% 703
2025
Q2 		$327K Buy
24,024
+9,753
+68% +$88.9K 0.01% 796
2025
Q1 		$119K Buy
+14,271
New +$180K ﹤0.01% 894

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Chicago Partners Investment Group's TXG Position: Q2 2026 in Review

Chicago Partners Investment Group reduced its 10x Genomics (TXG) stake by 21% in Q2 2026, selling an estimated $272K and leaving 39,561 shares worth $1.9M. The position accounts for 0.04% of the portfolio, ranked #388.

Chicago Partners Investment Group first reported a position in TXG in Q1 2025 and has held it in 6 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Chicago Partners Investment Group held 39,561 shares of 10x Genomics worth $1.9M as of Q2 2026.
  • Chicago Partners Investment Group sold 10,383 10x Genomics shares in Q2 2026, an estimated $272K.
  • 10x Genomics made up 0.04% of Chicago Partners Investment Group's portfolio in Q2 2026, its #388 holding.
  • Chicago Partners Investment Group first reported a position in 10x Genomics in Q1 2025 and has held it in 6 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.